Efficient Gene Editing for Heart Disease via ELIP-Based CRISPR Delivery System

The study investigates the use of echogenic liposomes (ELIP) combined with ultrasound as a delivery system for CRISPR/Cas9 complexes targeting heart disease. It demonstrates that ELIP significantly enhances the delivery and gene editing efficiency in cardiomyocytes both in vitro and in vivo, using mouse neonatal ventricular myocytes and rat hearts. The method showed improved penetration and effectiveness of gene editing, achieving up to 59.6% cleavage efficiency, and offers a promising non-invasive approach for targeted gene therapy in heart diseases. However, further optimization and extensive preclinical testing are needed to ensure safety and efficacy.